To ensure that ATG7 was suppressed in vivo in response to ATG7i-SPNP treatment, we performed immunohistochemistry on mIDH1 glioma bearing mice treated with ATG7i-SPNP (Fig. 9e, Supplementary Fig. 25). Here, ATG7 is linked to central nervous system cancer.